Browsing by Author "Cross M."

Now showing items 1-1 of 1

CD28 Superagonistic Activation of T Cells Induces a Tumor Cell-Like Metabolic Program

Thaventhiran T.; Wong W.; Alghanem A.F.; Alhumeed N.; Aljasir M.A.; Ramsey S.; Sethu S.; Yeang H.X.A.; Chadwick A.E.; Cross M.; Webb S.D.; Djouhri L.; Ball C.; Stebbings R.; Sathish J.G.... more authors ... less authors ( Mary Ann Liebert Inc. , 2019 , Article)
CD28 superagonist (CD28SA), a therapeutic immunomodulatory monoclonal antibody triggered rapid and exaggerated activation of CD4+ effector memory T cells (TEMs) in humans with unwanted serious adverse effects. It is well ...